Financiere de Tubize SA
XBRU:TUB
Intrinsic Value
Financiere de Tubize SA is a holding company, which engages in investing in biopharmaceuticals industry. [ Read More ]
The intrinsic value of one
TUB
stock under the Base Case scenario is
41.69
EUR.
Compared to the current market price of 95.8 EUR,
Financiere de Tubize SA
is
Overvalued by 56%.
Financiere de Tubize SA's market capitalization is 4.3B EUR.
TUB stock price is 95.8 EUR.
TUB stock (41.69 EUR) is 56% less than its price (95.8 EUR).
TUB stock (0.22 EUR) is 100% less than its price (95.8 EUR). Open Relative Valuation
TUB has upside potential of 43% compared to the average analyst price target.
Open Wall St Estimates
TUB has positive three-year average ROE (Return on Equity): 9%. The company is efficient at transforming stockholders' equity into net income.
TUB has positive three-year average ROIC (Return on Invested Capital): 8%. The company is efficient at using invested capital to generate operating income.
TUB's ROE (Return on Equity) has decreased in the last 3 years from 10% to 4%.
TUB's ROE (Return on Equity) for the past 12 months is very low and is equal to 4%.
TUB's ROIC (Return on Invested Capital) has decreased in the last 3 years from 9% to 0%.
TUB's ROIC (Return on Invested Capital) for the past 12 months is very low and is equal to 0%.
TUB's Revenue has dropped by 99% over the past 12 months.
TUB has positive Operating Income for the last twelve months.
TUB has positive Net Income for the last twelve months.
TUB has negative Free Cash Flow for the last twelve months.
TUB has positive Gross Profit for the last twelve months.
TUB's Revenue has been falling by 85% per year for the last 3 years.
TUB's short-term liabilties (49m EUR) exceed its short-term assets (2m EUR).
TUB's long-term assets (2B EUR) exceed its long-term liabilties (49m EUR).
TUB's D/E (Debt to Equity) is very low and is equal to 0.
TUB's Altman Z-Score is very high and is equal to 40.04.
Valuation Backtest
Financiere de Tubize SA
Run backtest to discover the historical profit from buying and selling
TUB
stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Financiere de Tubize SA
Balance Sheet Decomposition
Financiere de Tubize SA
| Current Assets | 1.6m |
| Cash & Short-Term Investments | 1.6m |
| Other Current Assets | 60.4k |
| Non-Current Assets | 1.9B |
| Long-Term Investments | 1.9B |
| Current Liabilities | 48.6m |
| Accounts Payable | 225k |
| Other Current Liabilities | 48.4m |
Earnings Waterfall
Financiere de Tubize SA
|
Revenue
|
993.3k
EUR
|
|
Cost of Revenue
|
-430
EUR
|
|
Gross Profit
|
992.9k
EUR
|
|
Operating Expenses
|
2.5k
EUR
|
|
Operating Income
|
995.4k
EUR
|
|
Other Expenses
|
92.1m
EUR
|
|
Net Income
|
93.1m
EUR
|
Free Cash Flow Analysis
Financiere de Tubize SA
TUB Profitability Score
Profitability Due Diligence
Financiere de Tubize SA's profitability score is 47/100. The higher the profitability score, the more profitable the company is.
Score
Financiere de Tubize SA's profitability score is 47/100. The higher the profitability score, the more profitable the company is.
TUB Solvency Score
Solvency Due Diligence
Financiere de Tubize SA's solvency score is 67/100. The higher the solvency score, the more solvent the company is.
Score
Financiere de Tubize SA's solvency score is 67/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
TUB Price Targets Summary
Financiere de Tubize SA
According to Wall Street analysts, the average 1-year price target for
TUB
is 137.45 EUR
with a low forecast of 135.85 EUR and a high forecast of 141.75 EUR.
Shareholder Return
TUB Price
Financiere de Tubize SA
| Average Annual Return | 6.63% |
| Standard Deviation of Annual Returns | 21.46% |
| Max Drawdown | -39% |
| Market Capitalization | 4.3B EUR |
| Shares Outstanding | 44 512 600 |
| Percentage of Shares Shorted |
N/A
|
Company Profile
Financiere de Tubize SA
Country
Industry
Market Cap
Dividend Yield
Description
Financiere de Tubize SA is a holding company, which engages in investing in biopharmaceuticals industry. The company is headquartered in Brussels, Bruxelles-Capitale. The firm holds minor capital in UCB SA. UCB is a Belgian pharmaceutical and specialty chemical company that specializes in two therapeutic areas: diseases of the central nervous system (CNS) and immunology. UCB, together with its subsidiaries, has research and development facilities in Belgium, Germany, Japan, the United Kingdom and the United States.
Contact
IPO
Employees
Officers
The intrinsic value of one
TUB
stock under the Base Case scenario is
41.69
EUR.
Compared to the current market price of 95.8 EUR,
Financiere de Tubize SA
is
Overvalued by 56%.
You don't have any saved screeners yet
